SlideShare a Scribd company logo
1 of 14
ANTICHOLINESTERASES
KANAV BHANOT
ROLL NO. 5
CONTENTS
• GENERAL- Anticholinesterases
• MECHANISM OF ACTION
• THERAPEUTIC USES
• ADVERSE DRUG REACTIONS
• ORGANOPHOSPHOROUS POISONING
(TREATMENT)
ANTICHOLINESTERASES
The Indirectly-acting CHOLINERGIC DRUGS are also
known as ANTICHOLINESTERASES.
Anticholinesterases are drugs that increase the level
of acetylcholine after it is released from cholinergic
nerve endings by inhibiting both
acetylcholinesterase and butyrylcholinesterase.
They increase the level of Acetylcholine.
They act where Ach is physiologically released.
MECHANISM OF ACTION
They act by increasing the concentration of Ach at
cholinoceptors by inhibiting AchE. Thus they prevent
the degradation of Ach into choline and acetate.
The anti-ChEs react with the enzyme essentially in the
same way as ACh.
The carbamates and phosphates respectively
carbamylate and phosphorylate the esteratic site of
the enzyme.
CONTD.
The acetylated enzyme reacts with water extremely
rapidly and the esteratic site is freed in a fraction of a
millisecond, whereas THE CARBAMYLATED ENZYME
(REVERSIBLE INHIBITORS) REACTS SLOWLY AND THE
PHOSPHORYLATED ENZYME (IRREVERSIBLE INHIBITORS)
REACTS EXTREMELY SLOWLY.
It is noteworthy that edrophonium and tacrine attach only
to the anionic site and do not form covalent bonds with
the enzyme(REVERSIBLE INHIBITION), while
organophosphates attach only to the esteratic site
forming covalent bonds (IREVERSIBLE INHIBITION).
THERAPEUTIC USES
I. EYES
1. Glaucoma
Acute congestive glaucoma: Pilocarpine is the preferred
cholinergic drug (pilocarpine eye drops 0.5-4% every 4-6
hourly), the main action is that they improve the aqueous
outflow. Physostigmine (0.1%) is used to supplement action
of pilocarpine in closed angle glaucoma.
2. Pilocarpine or Physostigmine is used alternate with a
mydriatic in iritis, uveitis or corneal ulcer.
II. ALZHEIMER’S DISEASE
Treatment: Cholinergic replacement using cholinesterase
inhibitors such as:
Donepezil 5-10 mg/day (drug of choice)
Rivastigmine 1.5 mg BID (max: 12 mg/day)
III. POST-OPERATIVE AND NEUROGENIC ILEUS AND
URINARY RETENTION
Neostigmine: 0.5-2mg SC
IV. MYAESTHENIA GRAVIS
DIAGNOSIS- Edrophonium is used for Tensilon test .
TREATMENT-
Anti-cholinesterase agent (increase Ach)
1.Pyridostigmine 60-120 mg 3-4 times/day orally
[less frequent dosing compared to Neostigmine]
2. or Pyridostigmine 2 mg IM
3. Or Neostigmine 15 mg q 6hourly
V. POST-OPERATIVE DECURARIZATION
Neostigmine: 0.5-2mg IV Or Edrophonium
VI. COBRA BITE (release a ‘curare-like neuro-toxin’ )
Treatment: Neostigmine/pyridostigmine
VII. BELLADONNA POISONING (Atropine poisoning)
Physostigmine 0.5-2mg is used by IV route.
ADVERSE DRUG REACTIONS
1. Nausea, Increased Salivation, Increased
Sweating
2. Flushing, Bradycardia
3. Bronchospasm
4. Abdominal Pain, Diarrhoea
5. Increased Urination
6. At High Dose: Convulsions ; Skl. Muscle
weakness
7. ADR On Eyes When Used As Eye Drops:
Miosis, Decrease Vision In Dim-light, Impaired
Accommodation.
ORGANOPHOSPHOROUS POISONING
(TREATMENT)
1. Termination of further exposure to the poison— fresh
air, wash the skin and mucous membranes with soap
and water, gastric lavage according to need.
2. Maintain patent airway, positive pressure respiration if
it is failing.
3. Supportive measures—maintain BP, hydration, control
of convulsions with judicious use of diazepam.
4. Specific antidotes—
(a)Atropine
(b)Cholinesterase reactivators
(A) ATROPINE
It is highly effective in counteracting the muscarinic
symptoms, but higher doses are required to antagonize
the central effects.
It does not reverse peripheral muscular paralysis which
is a nicotinic action.
All cases of anti-ChE (carbamate or organophosphate)
poisoning must be promptly given ATROPINE 2 mg I.V.
REPEATED EVERY 10 MIN till dryness of mouth or other
signs of atropinization appear
Continued treatment with maintenance doses may be
required for 1–2 weeks.
(B) CHOLINESTERASE REACTIVATORS
 Oximes are used to restore neuromuscular transmission
only in case of organophosphate anti-ChE poisoning.
 The phosphorylated ChE reacts very slowly or not at all
with water. However, if more reactive OH groups in the
form of oximes are provided, reactivation occurs more
than a million times faster.
 Pralidoxime 1-2 mg (30mg/kg), IV as 15-30 min infusion
[max 12g]
 Oximes improve action at nicotinic sites.
 It should be administered within 48 hours of
organophosphorus poisoning; otherwise when ageing
occurs; the phosphorylated enzyme becomes resistant to
hydrolysis (following loss of an alkyl group).
Anticholinesterases

More Related Content

What's hot

What's hot (20)

Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Sedative Hypnotic
Sedative HypnoticSedative Hypnotic
Sedative Hypnotic
 
Skeletal Muscle Relaxants
Skeletal Muscle RelaxantsSkeletal Muscle Relaxants
Skeletal Muscle Relaxants
 
parasympathomimetics drugs
  parasympathomimetics drugs  parasympathomimetics drugs
parasympathomimetics drugs
 
ANS pharmacology ppt
ANS pharmacology pptANS pharmacology ppt
ANS pharmacology ppt
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugs
 
Drugs for Congestive Heart Failure
Drugs for Congestive Heart FailureDrugs for Congestive Heart Failure
Drugs for Congestive Heart Failure
 
General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
 
Antianginal drug
Antianginal drugAntianginal drug
Antianginal drug
 
3.cholinergic drugs
3.cholinergic drugs3.cholinergic drugs
3.cholinergic drugs
 
Opioid analgesic
Opioid analgesicOpioid analgesic
Opioid analgesic
 
Antiadrenergic system and drugs
Antiadrenergic system and drugsAntiadrenergic system and drugs
Antiadrenergic system and drugs
 
NSAID'S --ASPIRIN
NSAID'S --ASPIRINNSAID'S --ASPIRIN
NSAID'S --ASPIRIN
 
Drugs used in bronchial asthma
Drugs used in bronchial asthmaDrugs used in bronchial asthma
Drugs used in bronchial asthma
 
Antianginal Drugs
Antianginal DrugsAntianginal Drugs
Antianginal Drugs
 
centrally acting muscle relaxants
centrally acting muscle relaxantscentrally acting muscle relaxants
centrally acting muscle relaxants
 
Diuretics...
Diuretics...Diuretics...
Diuretics...
 
Adrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blockerAdrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blocker
 
calcium channel blockers
calcium channel blockerscalcium channel blockers
calcium channel blockers
 

Similar to Anticholinesterases

Cholinergic drugs 1 (1)
Cholinergic drugs 1 (1)Cholinergic drugs 1 (1)
Cholinergic drugs 1 (1)
Mary Hair
 
anticholinestrase lucky.pptx for learnin
anticholinestrase lucky.pptx for learninanticholinestrase lucky.pptx for learnin
anticholinestrase lucky.pptx for learnin
RakshatNayak1
 
Antimuscarinic Agents
Antimuscarinic Agents Antimuscarinic Agents
Antimuscarinic Agents
RABBI
 
Vinayak atropine glyco
Vinayak atropine glycoVinayak atropine glyco
Vinayak atropine glyco
dr anurag giri
 
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptxCHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
OcquliVictor
 

Similar to Anticholinesterases (20)

Drugs modulating cholinesterase enzyme
Drugs modulating cholinesterase enzymeDrugs modulating cholinesterase enzyme
Drugs modulating cholinesterase enzyme
 
Anticholinestrases
AnticholinestrasesAnticholinestrases
Anticholinestrases
 
L P 2 Cholinoergic drugs.pdf
L P 2 Cholinoergic drugs.pdfL P 2 Cholinoergic drugs.pdf
L P 2 Cholinoergic drugs.pdf
 
L P 2 Cholinoergic drugs.pdf
L P 2 Cholinoergic drugs.pdfL P 2 Cholinoergic drugs.pdf
L P 2 Cholinoergic drugs.pdf
 
Drugs Acting on Autonomic Nervous System
Drugs Acting on Autonomic Nervous SystemDrugs Acting on Autonomic Nervous System
Drugs Acting on Autonomic Nervous System
 
L2 ans pharmacology 2017 2018
L2 ans pharmacology 2017 2018L2 ans pharmacology 2017 2018
L2 ans pharmacology 2017 2018
 
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholyticsNewer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
 
Catecholamines & noncatecholamines
Catecholamines & noncatecholaminesCatecholamines & noncatecholamines
Catecholamines & noncatecholamines
 
Anti cholinergics
Anti cholinergicsAnti cholinergics
Anti cholinergics
 
Class antidotes
Class antidotesClass antidotes
Class antidotes
 
drugs acting on autonomic nervous system
drugs acting on autonomic nervous systemdrugs acting on autonomic nervous system
drugs acting on autonomic nervous system
 
Parasympathomimetic drugs
Parasympathomimetic  drugsParasympathomimetic  drugs
Parasympathomimetic drugs
 
Cholinergic drugs 1 (1)
Cholinergic drugs 1 (1)Cholinergic drugs 1 (1)
Cholinergic drugs 1 (1)
 
Case cholinergic for recording.pptx
Case cholinergic for recording.pptxCase cholinergic for recording.pptx
Case cholinergic for recording.pptx
 
anticholinestrase lucky.pptx for learnin
anticholinestrase lucky.pptx for learninanticholinestrase lucky.pptx for learnin
anticholinestrase lucky.pptx for learnin
 
Antimuscarinic Agents
Antimuscarinic Agents Antimuscarinic Agents
Antimuscarinic Agents
 
L2
L2L2
L2
 
Anti cholinergic drugs
Anti cholinergic drugsAnti cholinergic drugs
Anti cholinergic drugs
 
Vinayak atropine glyco
Vinayak atropine glycoVinayak atropine glyco
Vinayak atropine glyco
 
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptxCHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
CHOLINERGIC DRUGS by agen Moses in pharmacology.pptx
 

Recently uploaded

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 

Recently uploaded (20)

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 

Anticholinesterases

  • 2. CONTENTS • GENERAL- Anticholinesterases • MECHANISM OF ACTION • THERAPEUTIC USES • ADVERSE DRUG REACTIONS • ORGANOPHOSPHOROUS POISONING (TREATMENT)
  • 3. ANTICHOLINESTERASES The Indirectly-acting CHOLINERGIC DRUGS are also known as ANTICHOLINESTERASES. Anticholinesterases are drugs that increase the level of acetylcholine after it is released from cholinergic nerve endings by inhibiting both acetylcholinesterase and butyrylcholinesterase. They increase the level of Acetylcholine. They act where Ach is physiologically released.
  • 4. MECHANISM OF ACTION They act by increasing the concentration of Ach at cholinoceptors by inhibiting AchE. Thus they prevent the degradation of Ach into choline and acetate. The anti-ChEs react with the enzyme essentially in the same way as ACh. The carbamates and phosphates respectively carbamylate and phosphorylate the esteratic site of the enzyme.
  • 5. CONTD. The acetylated enzyme reacts with water extremely rapidly and the esteratic site is freed in a fraction of a millisecond, whereas THE CARBAMYLATED ENZYME (REVERSIBLE INHIBITORS) REACTS SLOWLY AND THE PHOSPHORYLATED ENZYME (IRREVERSIBLE INHIBITORS) REACTS EXTREMELY SLOWLY. It is noteworthy that edrophonium and tacrine attach only to the anionic site and do not form covalent bonds with the enzyme(REVERSIBLE INHIBITION), while organophosphates attach only to the esteratic site forming covalent bonds (IREVERSIBLE INHIBITION).
  • 6. THERAPEUTIC USES I. EYES 1. Glaucoma Acute congestive glaucoma: Pilocarpine is the preferred cholinergic drug (pilocarpine eye drops 0.5-4% every 4-6 hourly), the main action is that they improve the aqueous outflow. Physostigmine (0.1%) is used to supplement action of pilocarpine in closed angle glaucoma. 2. Pilocarpine or Physostigmine is used alternate with a mydriatic in iritis, uveitis or corneal ulcer.
  • 7. II. ALZHEIMER’S DISEASE Treatment: Cholinergic replacement using cholinesterase inhibitors such as: Donepezil 5-10 mg/day (drug of choice) Rivastigmine 1.5 mg BID (max: 12 mg/day) III. POST-OPERATIVE AND NEUROGENIC ILEUS AND URINARY RETENTION Neostigmine: 0.5-2mg SC
  • 8. IV. MYAESTHENIA GRAVIS DIAGNOSIS- Edrophonium is used for Tensilon test . TREATMENT- Anti-cholinesterase agent (increase Ach) 1.Pyridostigmine 60-120 mg 3-4 times/day orally [less frequent dosing compared to Neostigmine] 2. or Pyridostigmine 2 mg IM 3. Or Neostigmine 15 mg q 6hourly
  • 9. V. POST-OPERATIVE DECURARIZATION Neostigmine: 0.5-2mg IV Or Edrophonium VI. COBRA BITE (release a ‘curare-like neuro-toxin’ ) Treatment: Neostigmine/pyridostigmine VII. BELLADONNA POISONING (Atropine poisoning) Physostigmine 0.5-2mg is used by IV route.
  • 10. ADVERSE DRUG REACTIONS 1. Nausea, Increased Salivation, Increased Sweating 2. Flushing, Bradycardia 3. Bronchospasm 4. Abdominal Pain, Diarrhoea 5. Increased Urination 6. At High Dose: Convulsions ; Skl. Muscle weakness 7. ADR On Eyes When Used As Eye Drops: Miosis, Decrease Vision In Dim-light, Impaired Accommodation.
  • 11. ORGANOPHOSPHOROUS POISONING (TREATMENT) 1. Termination of further exposure to the poison— fresh air, wash the skin and mucous membranes with soap and water, gastric lavage according to need. 2. Maintain patent airway, positive pressure respiration if it is failing. 3. Supportive measures—maintain BP, hydration, control of convulsions with judicious use of diazepam. 4. Specific antidotes— (a)Atropine (b)Cholinesterase reactivators
  • 12. (A) ATROPINE It is highly effective in counteracting the muscarinic symptoms, but higher doses are required to antagonize the central effects. It does not reverse peripheral muscular paralysis which is a nicotinic action. All cases of anti-ChE (carbamate or organophosphate) poisoning must be promptly given ATROPINE 2 mg I.V. REPEATED EVERY 10 MIN till dryness of mouth or other signs of atropinization appear Continued treatment with maintenance doses may be required for 1–2 weeks.
  • 13. (B) CHOLINESTERASE REACTIVATORS  Oximes are used to restore neuromuscular transmission only in case of organophosphate anti-ChE poisoning.  The phosphorylated ChE reacts very slowly or not at all with water. However, if more reactive OH groups in the form of oximes are provided, reactivation occurs more than a million times faster.  Pralidoxime 1-2 mg (30mg/kg), IV as 15-30 min infusion [max 12g]  Oximes improve action at nicotinic sites.  It should be administered within 48 hours of organophosphorus poisoning; otherwise when ageing occurs; the phosphorylated enzyme becomes resistant to hydrolysis (following loss of an alkyl group).

Editor's Notes

  1. The half-life of reactivation of carbamylated enzyme (about 30 min) is less than that of synthesis of fresh enzyme protein, while that of phosphorylated enzyme (in days) is more than the regeneration time. The phosphorylated enzyme may also undergo ‘aging’ by the loss of one of the alkyl groups and become totally resistant to hydrolysis